Pharmacovigilance Outsourcing Market Will Surge at 15.7% CAGR to Hit $7.5 Bn by 2024 |IBM, Accenture, Cognizant, HCL, Novartis, Oracle and 27+ Key Players Profiled - Global Market Insights

Monday, December 10, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

SELBYVILLE, Delaware, December 10, 2018 /PRNewswire/ --

U.S. pharmacovigilance outsourcing market valued at

USD 783.2 million revenue in 2017, dominated North America region is estimated to witness similar trend during the forthcoming years. The high growth is attributed to strong foothold of major pharma and medical
device companies coupled with extensive drug development activities in the U.S. Moreover, high healthcare expenditure in the country and growing concern regarding drug safety and adverse drug reactions among the population will boost pharmacovigilance outsourcing business growth.

     (Logo: https://mma.prnewswire.com/media/661916/GMI.jpg )

Global Pharmacovigilance Outsourcing Market will surpass USD 7.5 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing emphasis of several pharma and biopharma companies on new drug development for treatment of chronic diseases is one of the key drivers that will render positive impact on the pharmacovigilance (PV) outsourcing market growth. Pharmaceutical companies need to focus on several pharmacovigilance activities including remote monitoring for clinical trials, clinical operations, regulatory affairs, statistical analysis, quality assurance, evaluation and approvals of the project with necessary clearances and documentation. Setting up in-house PV department is not always cost effective and involves several challenges such as high costs for maintaining compliance levels and availability of trained in-house human resource. Growing inclination of pharma companies towards PV outsourcing facilities offering aforementioned functions will boost pharmacovigilance outsourcing industry growth in the coming years.

Furthermore, pharmaceutical drugs used in prevention and treatment of diseases have a high risk of adverse drug reactions (ADRs) that can cause serious harm to patients. This has led to increased focus of companies on monitoring of adverse drug reactions throughout the product life cycle, from pre-clinical trials to post-market surveillance. Thus, growing need for detection, assessment, understanding and prevention of ADRs will surge the demand for pharmacovigilance activities thereby accelerating the market growth. However, issues pertaining to data security and dearth of skilled professionals for performing PV functions may impede pharmacovigilance outsourcing business growth during the forecast period.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3030

Post-marketing services segment dominated the pharmacovigilance outsourcing market with USD 2.1 billion revenue in 2017 and is estimated to show significant growth over the analysis timeline. Segmental growth is attributable to the increasing number of ADRs associated with the newly developed drugs. Growing demand for several post-marketing services including adverse event case analysis and reporting, regulatory submission, reconciliation of pharmacovigilance database with clinical database and population studies & pharmaco-epidemiology assessment will spur the segment size.

Contract research organizations (CROs) segment accounted for the largest revenue share in 2017 and is estimated to witness 15.9% CAGR during the forecast timeframe. The segment growth is attributed to various case management activities that are majorly outsourced to the CROs. Increasing focus of the top CROs including IQVIA, Parexel and SIRO Clinpharm on developing innovative PV services such as medical writing, safety surveillance services and case processing services will further accelerate the segment growth in coming years.

Browse key industry insights spread across 230 pages with 199 market data tables & 7 figures & charts from the report, "Pharmacovigilance Outsourcing Market Size By Service (Pre-marketing Services {Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review}) Post-marketing Services {Knowledge Process Outsourcing Services, IT Solutions and Services}), By Service Providers (Contract Research Organizations, Business Processing Outsourcing), Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024" in detail along with the table of contents: 

https://www.gminsights.com/industry-analysis/pharmacovigilance-outsourcing-market

China pharmacovigilance outsourcing market held significant revenue share in 2017 and is projected to show highest CAGR of 16.7% over the forecast timeframe. The growth is attributable to the comprehensive pharmacovigilance system in China that covers organizations and regulations related to pharmacovigilance outsourcing. Furthermore, availability of Adverse Drug Reaction (ADR) Monitoring System, a spontaneous reporting system in China that connects the four-level pharmacovigilance network will render positive impact on the market growth.

Prominent industry players operating in the pharmacovigilance outsourcing market are Accenture, Bioclinica, , Clintec, Cognizant, Covance, Ergomed, Genpact, IBM Corporation, ICON, iGATE Corporation, iMED Global Corporation, Infosys, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PRA Health Sciences, SIRO Clinpharm, Symogen, Syneos Health, Tata Consultancy Services (TCS) and Tech Mahindra. Key industry players are majorly focusing on strategic initiatives including acquisitions, merger and partnerships to strengthen market position and capitalize on market opportunities. For instance, in June 2018, Genpact acquired Commonwealth Informatics, a leading provider of cloud-based drug safety analytics services and products for medical research and healthcare delivery. The strategy will help Genpact to strengthen its pharmacovigilance AI capabilities for ensuring drug safety thereby fostering company's growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3030

Browse Related Reports: 

  • Medical Biomimetics Market Size Forecast 2018 - 2024  The Medical Biomimetics Market crossed USD 23.5 billion in 2017 and is expected to witness growth of over 5.5% CAGR from 2018 to 2024 with favourable funding scenario for research and development of biomimetics.https://www.gminsights.com/industry-analysis/medical-biomimetics-market
  • Craniomaxillofacial Devices Market Size Outlook 2018 - 2024  The Craniomaxillofacial Devices Market exceeded USD 1.2 billion in 2017 and is expected to witness more than 6.8% CAGR from 2018 to 2024 with growing demand for minimally invasive reconstruction surgeries instead of traditional methods.https://www.gminsights.com/industry-analysis/craniomaxillofacial-devices-market

About Global Market Insights 

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: +1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: http://news-researchers.com

Connect with us: Facebook | Google+ | LinkedIn | Twitter

SOURCE Global Market Insights, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store